3 fda approved drugs, 2 of which will continue exponential growth.

$XERS Truly so strange, everything Xeris had in its programme has been met, briefly 3 FDA approved products, collaborations with major pharmacies and much, much more.

$XERS Xeris is gold 3 approved fda products on the market with increasing sales and this goldmine coming, buy now if you can!

$XERS With all the 3 approved FDA products and this levo good news this should be trade at 6-8$ Insane stock price, so buy buy buy all!

FDA is more easier going nowaday.

Arimoclomol has a very good, if not great, chance of approval with the 4 plus years of data in Travis's hands and his relationship with the FDA.

Excited to see 4 year safety data and accelerated timeline for submission with Travis 100% focused on it.

The Q3 Arimoclomol NDA is certainly another growth catalyst.

This system and the way it is set up will serendipitously help our pps greatly come Q3 when KemPharm re-submits Arimoclomol's NDA.

Here's to a great 2023 with scripts continuing increasing by 500 plus patients per week, great IH results and submitting to the fda our arimiclomol application

That along with collaborating with the fda stated in our CC on arimiclomol I would think our chance is good on getting that approved.

Now that we know Arimoclomol's NDA is postponed till Q3, I truly believe we have a sleeper here.

ARDX got a very difficult ADCOM and still came out winning.

This will def help expedite FDA approval while also making costs for trials way less expensive! https://investors.kempharm.com/news-releases/news-release-details/kempharm-receives-fda-orphan-drug-designation

$AMD The AI engine is built with a so-called "dataflow architecture" that makes it well-suited for AI and signal processing applications that need a mix of high performance and energy efficiency.

Great run $CLF up with the US dollar retreating Steel looking good BEST TRADE HERE IS SRPT for FDA NEWS COMING ANY DAY!!!

but nice run on earnings from AMD SRPT will have a FDA BLA Acceptance filing any day now expect 112 then gap up to 140-150 on news with no adcom and FAST TRACK by FDA!

data center/business applications and embedded will grow faster than any slowdowns in other sectors.